ENTITY

Ensysce Biosciences (ENSC US)

Analysis

Health Care • United States

Ensysce Biosciences, Inc. operates as a clinical stage biotech company. The Company focuses on stemming the prescription drug abuse epidemic. Ensysce Biosciences serves customers worldwide.

Refresh

Company Event • 08 Nov 2024 22:30 • Upcoming

Add To Calendar

Q3 2024

Company Event • 15 Aug 2024 04:00 • Upcoming

Add To Calendar

Q2 2024

Company Event • 13 May 2024 19:00 • Upcoming

Add To Calendar

Q1 2024

Company Event • 21 Mar 2024 23:00 • Latest

Q4 2023

No more events

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00